Intellia Therapeutics Inc (NTLA)
Cost of Revenue
$87.17M
TTM · Period ending: · USD
NTLA Cost of Revenue
Latest reported$87.17Mperiod ending
Latest reported$87.17Mperiod ending
NTLA TTM Cost of Revenue ($11.17M → $87.17M)
TTM cost of revenue
High-resolution chart · PNG
NTLA cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 87,166,000 | |
| 167,699,000 | |
| 165,497,000 | |
| 276,359,000 | |
| 306,584,000 | |
| 228,650,000 | |
| 231,162,000 | |
| 116,751,000 | |
| 9,867,000 | |
| 122,544,000 | |
| 217,148,000 | |
| 314,716,000 | |
| 409,077,000 | |
| 384,000,000 | |
| 419,979,000 | |
| 391,106,000 | |
| 354,941,000 | |
| 323,626,000 | |
| 229,807,000 | |
| 196,877,000 | |
| 176,147,000 | |
| 155,034,000 | |
| 150,408,000 | |
| 143,908,000 | |
| 131,665,000 | |
| 119,354,000 | |
| 108,413,000 | |
| 96,600,000 | |
| 92,324,000 | |
| 90,331,000 | |
| 89,115,000 | |
| 90,367,000 | |
| 84,611,000 | |
| 76,709,000 | |
| 67,647,000 | |
| 57,808,000 | |
| 48,188,000 | |
| 40,046,000 | |
| 31,840,000 | |
| 24,884,000 | |
| 20,481,000 | |
| 15,024,000 | |
| 11,170,000 | |
| 8,269,500 | |
| 4,822,500 |